|
BSGT Visiting Fellow Travel Award - Call for Applications 2008
The British Society for Gene Therapy (BSGT) is sponsoring a travel award to
enable young members of BSGT to travel and work in a foreign laboratory with
the aim of establishing new international collaborations.
It is intended to sponsor up to 3 fellowships per year each at £2000.
Applicants should normally be postdoctoral fellows in their first or second
postdoctoral appointment, employed in the UK and be members of BSGT.
Applications should be sent electronically to BSGT: info@bsgt.org
They should provide
-
- a CV and relevant publication list;
-
- an outline of the aim of the visit; and
-
- a plan of work agreed between the applicant and the heads of the sending and
host laboratories.
Preference will be given to proposals which aim at the submission of a
collaborative grant proposal during or following the visit.
A standing committee of BSGT will review and select proposals for funding within
8 weeks of the application deadline. The decision of the committee will not be
disputable.
Successful applicants will be obliged to provide the committee with a written
report on the achievements of their visit one month after completion of the
visit and also present an oral report at the BSGT Annual Conference.
The deadline for submissions is 5pm on Monday 30th June 2008.
BSGT Travel Award Visiting Fellows
2007
The recipients of the first BSGT Travel Award were Dr Steven Howe (Institute of
Child Health) and Dr Fiona Wilkinson (University of Manchester).
Dr Howe will visit the laboratory of Drs. David Williams and Mick Milsom of the
Cincinnati Children's Hospital Medical Centre, CCHMC, USA in order to advance a
project examining the use of non-integrating lentiviral vectors to manipulate
stem cell growth, survival and biology through transient expression of HOXB4.
Dr Wilkinson will initiate a collaborative project with Prof John Hopwood and Dr
Kim Hemsley of the Lysosomal Diseases Research Unit (LDRU), Women's and
Children's Hospital, Adelaide, South Australia in Adelaide. This project will
investigate the use of lentiviral vectors for autologous stem cell gene therapy
for Mucopolysaccharide diseases.
|